Effient and Icterus - a phase IV clinical study of FDA data

Summary:

Icterus is reported as a side effect among people who take Effient (prasugrel hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Aspirin, and have Angina unstable.

The phase IV clinical study analyzes which people have Icterus when taking Effient. It is created by eHealthMe based on reports of 9,155 people who have side effects when taking Effient from the FDA, and is updated regularly.

What is Effient?

Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,482 Effient users. Check the latest studies of Effient.

What is Icterus?

Icterus (yellowish pigmentation of the skin) is found to be associated with 2,076 drugs and 3,015 conditions by eHealthMe. Check the latest studies of Icterus.

On Mar, 31, 2026

9,155 people reported to have side effects when taking Effient.
Among them, 12 people (0.13%) have Icterus.

Among these 12 people:

How long have people been on Effient when they have Icterus? *

What is the gender of people who have Icterus when taking Effient? *

female: 25 %
male: 75 %

What is the age of people who have Icterus when taking Effient? *

What are other drugs people take besides Effient? *

What are other side effects people have besides Icterus? *

Blood Bilirubin Increased: 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Transaminases Increased: 3 people, 25.00%
Hepatitis (inflammation of the liver): 3 people, 25.00%
Nausea And Vomiting: 2 people, 16.67%
Drug Eruption (adverse drug reaction of the skin): 2 people, 16.67%
Malaise (a feeling of general discomfort or uneasiness): 2 people, 16.67%
Liver Injury: 2 people, 16.67%
Yellow Skin: 1 person, 8.33%
Hepatic Enzyme Increased: 1 person, 8.33%

What are the existing conditions these people have? *

Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 3 people, 25.00%
Percutaneous Coronary Intervention: 2 people, 16.67%
Type 2 Diabetes: 1 person, 8.33%
Stress And Anxiety: 1 person, 8.33%
Renal Cell Carcinoma Stage Iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes): 1 person, 8.33%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 8.33%
Cardiac Disorder: 1 person, 8.33%
Blood Pressure Abnormal: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Effient and have Icterus?

- Check whether Icterus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Effient:

Effient (9,482 reports)

Icterus treatments and more:

Icterus (33,621 reports)

Browse all side effects of Effient:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Icterus:

Icterus (2,076 drugs)

Browse all the conditions that are associated with Icterus:

Icterus (3,015 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prasugrel hydrochloride (the active ingredients of Effient) and Effient (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.